Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Microparticle Levels Are High in Patients with Hemophilia A and Can Be Further Increased by DDAVP Administration.

Andrea Artoni, MD, PhD, Elena Santagostino, MD PhD, Maria E. Mancuso, MD, Anna Lecchi, BSc, Pier M. Mannucci, MD

Blood (2007) 110 (11): 3139.

https://doi.org/10.1182/blood.V110.11.3139.3139

Published: 2007

Journal Articles

Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.

Elena Santagostino, MD, PhD, Maria E. Mancuso, MD, Armando Tripodi, BSc, Veena Chantarangkul, BSc, Mariagrazia Clerici, BSc, Simona M. Siboni, MD, Pier M. Mannucci, MD

Blood (2007) 110 (11): 1154.

https://doi.org/10.1182/blood.V110.11.1154.1154

Published: 2007

Journal Articles

Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.

Elena Santagostino, MD, Maria E. Mancuso, MD, Armando Tripodi, Veena Chantarangkul, Marigrazia Clerici, Cinzia Sei, Pier M. Mannucci, MD

Blood (2006) 108 (11): 1000.

https://doi.org/10.1182/blood.V108.11.1000.1000

Published: 2006

Journal Articles

A Randomized Crossover Study of High- and Standard-Dose Recombinant Factor VIIa for Treatment of Hemarthroses in Hemophiliacs with Inhibitors.

Elena Santagostino, MD, PhD, Maria E. Mancuso, MD, Angiola Rocino, MD, Giacomo Mancuso, MD, Francesco A. Scaraggi, MD, Massimo Morfini, MD, Filomena Daniele, MD, Giovanni Barillari, MD, Pier M. Mannucci, MD

Blood (2005) 106 (11): 323.

https://doi.org/10.1182/blood.V106.11.323.323

Published: 2005

Journal Articles

High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.

Maria E. Mancuso, MD, Elena Santagostino, MD, PhD, Maria G. Rumi, MD, Silvia Linari, MD, Antonio Coppola, MD, Angiola Rocino, MD, Alfonso Iorio, MD, Alfredo Dragani, MD, Giovanni Barillari, MD, Giuseppe Tagariello, MD, Roberto Nicolin, MD, Massimo Colombo, MD, Pier M. Mannucci, MD

Blood (2005) 106 (11): 3219.

https://doi.org/10.1182/blood.V106.11.3219.3219

Published: 2005

Journal Articles

Sustained Suppression of Hepatitis C by Pegylated Interferon and Ribavirin in Hemophilic Patients.

Elena Santagostino, MD, PhD, Maria E. Mancuso, MD, Francesca De Filippi, MD, Maria G. Rumi, MD, Massimo Colombo, MD, Pier M. Mannucci, MD

Blood (2004) 104 (11): 4096.

https://doi.org/10.1182/blood.V104.11.4096.4096

Published: 2004

Journal Articles

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Elena Santagostino, MD, PhD, Angiola Rocino, MD, Maria E. Mancuso, MD, Maria G. Mazzucconi, MD, Giacomo Mancuso, MD, Maria Messina, MD, Annarita Tagliaferri, MD, Matteo Luciani, MD, Elio Boeri, MD, Pier M. Mannucci, MD

Blood (2004) 104 (11): 37.

https://doi.org/10.1182/blood.V104.11.37.37

Published: 2004

NARROW

Microparticle Levels Are High in Patients with Hemophilia A and Can Be Further Increased by DDAVP Administration.

Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.

Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.

A Randomized Crossover Study of High- and Standard-Dose Recombinant Factor VIIa for Treatment of Hemarthroses in Hemophiliacs with Inhibitors.

High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.

Sustained Suppression of Hepatitis C by Pegylated Interferon and Ribavirin in Hemophilic Patients.

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

Microparticle Levels Are High in Patients with Hemophilia A and Can Be Further Increased by DDAVP Administration.

Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.

Thrombin Generation in Severe Hemophiliacs with Different Clinical Phenotype.

A Randomized Crossover Study of High- and Standard-Dose Recombinant Factor VIIa for Treatment of Hemarthroses in Hemophiliacs with Inhibitors.

High Efficacy of Combination Therapy with Pegylated Interferon and Ribavirin in Hemophiliacs with Chronic Hepatitis C.

Sustained Suppression of Hepatitis C by Pegylated Interferon and Ribavirin in Hemophilic Patients.

Impact of Early Factor VIII Exposure, Prophylaxis and Prenatal/Perinatal Events on Inhibitor Risk in Children with Hemophilia A: A Case-Control Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only